Announcement of Resolutions of the 2026 Fourth Extraordinary General Meeting

Guangji Pharmaceutical Co., Ltd.·August 5, 2026·7 pages

✨ AI Summary

Hubei Guangji Pharmaceutical Co., Ltd. held its 2026 fourth extraordinary general meeting on August 5, 2026. Shareholders approved all proposals, including the revised plan for the non-public issuance of A-shares and related feasibility reports. The meeting was attended by shareholders representing 33.4159% of the company's total shares. All resolutions were passed with significant majority support.

Summary generated by AI · Always verify with source document

Exchange Summary

EGM RESOLUTION

The Company held its 4th Extraordinary General Meeting of 2026 on 05 August 2026, during which the following proposal(s) was/were approved: 1. The Company's eligibility for A-share offering to specific parties 2. Adjustment of the plan for the 2026 A-share offering to specific parties 2.1. Stock type and par value 2.2. Method and date of issuance 2.3. Issuing targets and subscription method 2.4. Pricing base date, pricing principles and issue price 2.5. Issuing volume 2.6. Lockup period arrangement 2.7. Purpose and amount of the raised funds 2.8. Arrangement for the accumulated retained profits 2.9. Listing place 2.10. Valid period of the resolution 3. Preplan for the 2026 A-share offering to specific parties (revised) 4. Demonstration analysis report on the plan for 2026 A-share offering to specific parties (revised) 5. Feasibility analysis report on the use of funds to be raised from the 2026 A-share offering to specific parties (revised) 6. Diluted immediate return after the 2026 A-share offering to specific parties, filling measures, and commitments of relevant parties 7. No need to prepare a report on the use of previous raised funds 8. Connected transactions regarding the conditional share subscription agreement and its supplementary agreement to be signed with specific parties 9. Connected transactions involved in the 2026 A-share offering to specific parties 10. Full authorization to the board to handle matters regarding the A-share offering to specific parties 11. Shareholder return plan for the next three years from 2026 to 2028 12. Exemption of specific parties from the tender offer obligation

Provided by Shenzhen Stock Exchange

Full Translation

AI Translation· gemini_document

Stock Code: 000952 Stock Abbreviation: Guangji Pharmaceutical Announcement No.: 2026-060

Hubei Guangji Pharmaceutical Co., Ltd.

Announcement of Resolutions of the 2026 Fourth Extraordinary General Meeting

Special Reminder:

● No proposals were rejected at this general meeting.

● This general meeting did not involve any changes to resolutions previously passed at prior general meetings.

I. Meeting Convening and Attendance

On-site meeting time: August 5, 2026, 15:30
Online voting time: Through the Shenzhen Stock Exchange system, the specific time was 9:15–9:25, 9:30–11:30, and 13:00–15:00 on August 5, 2026; through the Shenzhen Stock Exchange internet voting system, the time was any time from 9:15 to 15:00 on August 5, 2026.
Meeting method: This general meeting was held using a combination of on-site voting and online voting.
Convener: The Board of Directors of Hubei Guangji Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company").
Host: Chairman Mr. Hu Ligang.
The convening and holding of this meeting complied with the relevant provisions of the Company Law of the People's Republic of China, the Rules Governing the Listing of Stocks on the Shenzhen Stock Exchange, the Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1—Standardized Operation of Main Board Listed Companies, and other laws, administrative regulations, departmental rules, normative documents, and the Articles of Association.
A total of 104 shareholders and shareholder representatives attended the on-site meeting and online voting, representing 114,950,527 shares, accounting for 33.4159% of the total shares of the listed company.

Among them: 1 shareholder and shareholder representative attended via on-site voting, representing 87,592,065 shares, accounting for 25.4628% of the total shares. 103 shareholders attended via online voting, representing 27,358,462 shares, accounting for 7.9530% of the total shares.

Overall attendance of small and medium shareholders: A total of 103 shareholders and shareholder representatives attended via on-site and online voting, representing 27,358,462 shares, accounting for 7.9530% of the total shares.

There were 9 directors in office, and 9 attended the meeting on-site or via communication; the Board Secretary and other senior management personnel attended the meeting as non-voting delegates. Lawyers from Hubei Zhongqin Law Firm attended the meeting to witness and issued a legal opinion.

II. Deliberation and Voting Results

The proposals at this general meeting were voted on using a combination of on-site and online voting. The results are as follows:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.